Kolexia
Italiano Antoine Oncologie médicale
Italiano Antoine
Oncologie médicale
Institut Bergonié
Bordeaux, France
1 K Activités
1.7 K Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Sarcomes Tumeurs du poumon Métastase tumorale Tumeurs des tissus mous Carcinomes Récidive tumorale locale Tumeurs stromales gastro-intestinales Carcinome pulmonaire à petites cellules Carcinome pulmonaire non à petites cellules

Collaborateurs

Voir plus
Blay Jean Yves
Blay Jean Yves
Centre Léon-Bérard, Lyon, France
Penel Nicolas
Penel Nicolas
Centre Oscar-Lambret, Lille, France
Le Cesne Axel
Le Cesne Axel
Gustave-Roussy, Villejuif, France
Toulmonde Maud
Toulmonde Maud
Institut Bergonié, Bordeaux, France

Industries

Voir plus
Bayer
33 collaboration(s)
Dernière en 2023
Roche
31 collaboration(s)
Dernière en 2023
GSK
6 collaboration(s)
Dernière en 2023
MSD
5 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
PACT: A Phase 1a/1b Study of a Novel Anti-PD-L1 Checkpoint Antibody (LY3300054) Administered Alone or in Combination With Other Agents in Advanced Refractory Solid Tumors (Phase 1a/1b Anti-PD-L1 Combinations in Tumors-PACT)
Essai Clinique (Lilly)   14 mars 2024
MULTISARC: Molecular Profiling of Advanced Soft-tissue Sarcomas. A Phase III Study
Essai Clinique (Institut National de la Santé Et de la Recherche Médicale, France)   05 mars 2024
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations: A Phase 2 Master Protocol to Assess the Efficacy and Safety of FORE8394, an Inhibitor of BRAF Class 1 and Class 2 Alterations, in Participants With Cancer Harboring BRAF Alterations
Essai Clinique (Fore Biotherapeutics)   05 mars 2024
CAMPFIRE: Children's and Young Adult Master Protocol for Innovative Pediatric Research
Essai Clinique (Lilly)   04 mars 2024
LIBRETTO-001: A Phase 1/2 Study of Oral Selpercatinib (LOXO-292) in Patients With Advanced Solid Tumors, Including RET Fusion-Positive Solid Tumors, Medullary Thyroid Cancer, and Other Tumors With RET Activation (LIBRETTO-001)
Essai Clinique (Loxo Oncology, Inc.)   01 mars 2024
Codon-specific KRAS mutations predict survival in advanced pancreatic cancer
ESMO Gastrointestinal Oncology   01 mars 2024
A Study of Tazemetostat in Adult Participants With Soft Tissue Sarcoma: A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma
Essai Clinique (Epizyme, Inc.)   29 février 2024
A Study to Compare the Blood Levels and Safety of Tazemetostat in Participants With Advanced Cancer and Moderate/Severe Liver Impairment to Participants With Advanced Cancer and Normal Liver Function: A Phase I, Open-label Multi-dose Pharmacokinetic and Safety Study of Oral Tazemetostat in Subjects With Moderate and Severe Hepatic Impairment With Advanced Malignancies
Essai Clinique (Epizyme, Inc.)   29 février 2024
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T cells.
Nature   28 février 2024
CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma
Essai Clinique (Lilly)   27 février 2024